No black box warning on record for Simbrinza
As of the latest FDA labeling reviewed, Simbrinza (BRINZOLAMIDE/BRIMONIDINE TARTRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Simbrinza medicine page for the complete safety profile.